tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:2256 Stock Latest News

Abbisko Therapeutics Unveils Promising Preclinical Cancer Drug Findings
Company AnnouncementsAbbisko Therapeutics Unveils Promising Preclinical Cancer Drug Findings
6d ago
2256
Abbisko’s Pimicotinib Shows Promising Results in Phase III TGCT Trial
PremiumCompany Announcements
Abbisko’s Pimicotinib Shows Promising Results in Phase III TGCT Trial
13d ago
2256
Abbisko Cayman Limited Grants Share Options to Directors and Employees
PremiumCompany Announcements
Abbisko Cayman Limited Grants Share Options to Directors and Employees
1M ago
2256
Abbisko Cayman Limited Engages in Significant Wealth Management Subscriptions
PremiumCompany Announcements
Abbisko Cayman Limited Engages in Significant Wealth Management Subscriptions
2M ago
2256
Abbisko’s PD-L1 Inhibitor ABSK043 Gains IND Clearance for NSCLC Treatment
PremiumCompany Announcements
Abbisko’s PD-L1 Inhibitor ABSK043 Gains IND Clearance for NSCLC Treatment
2M ago
2256
Abbisko’s Strategic Advancements and Promising Pipeline Drive Buy Rating
PremiumRatingsAbbisko’s Strategic Advancements and Promising Pipeline Drive Buy Rating
3M ago
Abbisko Cayman Limited Reports Key Milestones in Drug Development for H1 2025
Premium
Company Announcements
Abbisko Cayman Limited Reports Key Milestones in Drug Development for H1 2025
3M ago
2256
Abbisko Cayman Limited Enhances Governance with New Nomination Committee
Premium
Company Announcements
Abbisko Cayman Limited Enhances Governance with New Nomination Committee
3M ago
2256
Abbisko Therapeutics Initiates Phase 1 Trial for Innovative Cancer Drug ABSK131
PremiumCompany Announcements
Abbisko Therapeutics Initiates Phase 1 Trial for Innovative Cancer Drug ABSK131
3M ago
2256
Abbisko Cayman Limited Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Abbisko Cayman Limited Schedules Board Meeting for Interim Results
4M ago
2256
Abbisko Therapeutics to Present Promising Phase 2 Study Results at ESMO GI Congress
PremiumCompany Announcements
Abbisko Therapeutics to Present Promising Phase 2 Study Results at ESMO GI Congress
4M ago
2256
Abbisko Therapeutics Advances Achondroplasia Study with First Patient Enrollment
PremiumCompany Announcements
Abbisko Therapeutics Advances Achondroplasia Study with First Patient Enrollment
4M ago
2256
Abbisko Cayman Limited AGM Resolutions Passed
PremiumCompany AnnouncementsAbbisko Cayman Limited AGM Resolutions Passed
5M ago
2256
Abbisko Therapeutics Advances HCC Treatment with Irpagratinib Study
Premium
Company Announcements
Abbisko Therapeutics Advances HCC Treatment with Irpagratinib Study
5M ago
2256
Abbisko Cayman Limited’s CEO Increases Stake Amid Share Buyback Plan
Premium
Company Announcements
Abbisko Cayman Limited’s CEO Increases Stake Amid Share Buyback Plan
5M ago
2256
Abbisko Cayman Limited Addresses Criticism of Director
PremiumCompany Announcements
Abbisko Cayman Limited Addresses Criticism of Director
5M ago
2256
Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment
PremiumCompany Announcements
Abbisko Therapeutics’ Pimicotinib NDA Accepted by China NMPA for TGCT Treatment
5M ago
2256
Abbisko Secures $85 Million from Merck for Pimicotinib Global Rights
PremiumCompany Announcements
Abbisko Secures $85 Million from Merck for Pimicotinib Global Rights
5M ago
2256
Abbisko Therapeutics’ Irpagratinib Receives Breakthrough Therapy Designation for HCC Treatment
PremiumCompany Announcements
Abbisko Therapeutics’ Irpagratinib Receives Breakthrough Therapy Designation for HCC Treatment
5M ago
2256
Abbisko Therapeutics to Present Phase 3 Pimicotinib Results at 2025 ASCO Meeting
PremiumCompany AnnouncementsAbbisko Therapeutics to Present Phase 3 Pimicotinib Results at 2025 ASCO Meeting
5M ago
2256
Abbisko’s Pimicotinib Gains Priority Review in China for TGCT
Premium
Company Announcements
Abbisko’s Pimicotinib Gains Priority Review in China for TGCT
6M ago
2256
Abbisko Cayman Limited Announces 2025 AGM Agenda
Premium
Company Announcements
Abbisko Cayman Limited Announces 2025 AGM Agenda
6M ago
2256

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >